CASR and malignant tumor of parathyroid gland: It lowers parathyroid hormone (PTH) levels by increasing the sensitivity of the parathyroid calcium-sensing receptor (CaSR) to extracellular calcium.(5) As its primary mechanism of action in the treatment of parathyroid cancer, cinacalcet may interact with CaSR in the bone and/or kidneys.